Intervention not reported
Clinical outcome: blood pressure control, 26 weeks Multimodal/complex interventionf versus usual care · patients with hypertension
1 finding from 1 review
Intervention not reported
Clinical outcome: Health statush, depressioni, 6 weeks ATCS Plus versus enhanced usual care (plus information) · patients with hypertension
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication use Multimodal/complexk, ATCS Plus versus usual care or enhanced usual care (plus information) · patients with hypertension
1 finding from 1 review
Intervention not reported
Behavioural outcome: physical activity levels, 12 weeks IVR versus enhanced usual care · patients with hypertension
1 finding from 1 review
Intervention not reported
Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR, unidirectional ATCS versus various controls · patients with hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Behavioural outcome: smoking abstinence Multimodal/complex intervention, ATCS Plus, IVR versus (various) controls or usual care at median · patients with tobacco dependence
The intervention showed no clear difference in behavioural outcome: smoking abstinence Multimodal/complex… (low certainty).
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication use Multimodal/complex, ATCS Plus versus control (inactive IVR or self‐help booklet) · patients with tobacco dependence
1 finding from 1 review
Intervention not reported
Behavioural outcome: support programme enrolment ATCS Plus versus control (inactive IVR) · patients with tobacco dependence
1 finding from 1 review
Intervention not reported
Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR versus various controls · patients with tobacco dependence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Exacerbations requiring oral corticosteroids 48 weeks · adults with asthma
The intervention showed no clear difference in exacerbations requiring oral corticosteroids 48 weeks (moderate certainty).
1 finding from 1 review
Intervention not reported
Quality of life (AQLQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Serious adverse events 49 weeks · adults with asthma
The intervention showed no clear difference in serious adverse events 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission 49 weeks · adults with asthma
The intervention showed no clear difference in exacerbations requiring hospital admission 49 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Lung function (change in trough FEV1 L) · adults with asthma
1 finding from 1 review
Intervention not reported
Asthma control (ACQ) · adults with asthma
1 finding from 1 review
Intervention not reported
Any adverse events 49 weeks · adults with asthma
The intervention leads to lower any adverse events 49 weeks (high certainty).
1 finding from 1 review
Intervention not reported
Exacerbations Number of events · adults and children with purulent bronchiectasis
The intervention probably leads to lower exacerbations Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
Hospitalisations Number of events · adults and children with purulent bronchiectasis
The intervention showed no clear difference in hospitalisations Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
Emergence of resistance Number of events · adults and children with purulent bronchiectasis
The intervention probably leads to higher emergence of resistance Number of events (moderate certainty).
1 finding from 1 review
Intervention not reported
St George Respiratory Questionnaire (SGRQ) total Mean and standard deviation. Scale from 0 to 100 · adults and children with purulent bronchiectasis
1 finding from 1 review